A composition is provided for making a polyurethane that may be incorporated in various products, such as a sealant, a coating, a caulk, an electric potting compound, a membrane, a sponge, a foam, an adhesives, and a propellant binder. The composition includes one or more polyols, one or more isocyanate-group containing compounds having an isocyanate group functionality of at least two, and optionally one or more chain extenders. At least one of the polyols is a farnesene-based polyol having a number average molecular weight less than or equal to 100,000 g/mol and a viscosity at 25 C. less than 10,000 cP. The farnesene-based polyol may be a homopolymer or a copolymer of farnesene. The composition may also comprise additional polyols, such as a polyol of a homopolymer or copolymer of a polydiene. Methods of preparing a polyurethane are also provided.

The present disclosure provides novel polypeptides with 3-buten-2-ol dehydratase activity, polypeptides with catalytic activity in the conversion of 3-methyl-3-buten-2-ol to isoprene, and crystal structure data for one of such polypeptides. Methods of making and using the polypeptides and their related crystal structure data are also provided.

The present disclosure provides novel polypeptides with 3-buten-2-ol dehydratase activity, polypeptides with catalytic activity in the conversion of 3-methyl-3-buten-2-ol to isoprene, and crystal structure data for one of such polypeptides. Methods of making and using the polypeptides and their related crystal structure data are also provided.

A tackifying resin includes a farnesene-based polymer having monomeric units derived from a farnesene monomer and one or more optional comonomers selected from the group consisting of dienes, branched mono-olefins, and vinyl aromatics and has a softening point greater than or equal to 80 degrees Celsius. A method of making the farnesene-based polymer includes combining a farnesene monomer and a solvent and optionally adding one or more comonomers selected from the group consisting of dienes, branched mono-olefins, and vinyl aromatics, to provide a monomer feed, and polymerizing the monomer feed by combining the monomer feed with a Friedel-Crafts catalyst in a vessel. The tackifying resin may be combined with an elastomer to form a hot melt adhesive composition.

A latex and solution with UV-active monomers created using styrenic polymers created via the depolymerization of a polystyrene feedstock. In some embodiments the polystyrene feedstock contains recycle polystyrene. In some embodiments, the styrenic polymers contain olefins. In some embodiments, the latex and solution with UV-active monomers are used in ink formulations. In some embodiments, latex and solution UV-active monomers can replace styrenated acrylics within flexo and/or gravure ink formulations. Other applications of the latex and solution with UV-active monomers can include, but are not limited to, coatings, paints, adhesives. Additional applications of the latex can include but are not limited to immunoassays.

A latex and solution with UV-active monomers created using styrenic polymers created via the depolymerization of a polystyrene feedstock. In some embodiments the polystyrene feedstock contains recycle polystyrene. In some embodiments, the styrenic polymers contain olefins. In some embodiments, the latex and solution with UV-active monomers are used in ink formulations. In some embodiments, latex and solution UV-active monomers can replace styrenated acrylics within flexo and/or gravure ink formulations. Other applications of the latex and solution with UV-active monomers can include, but are not limited to, coatings, paints, adhesives. Additional applications of the latex can include but are not limited to immunoassays.

Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.

Polymers comprising a plurality of cannabinoids, methods of preparation thereof, and methods of use to treat a number of disease conditions are reported. Also provided are polymer coatings, films, fibers, and non-woven fabrics for a variety of topical applications including stents, bandages, sutures, and transdermal patches.

A latex and solution with UV-active monomers created using styrenic polymers created via the depolymerization of a polystyrene feedstock. In some embodiments the polystyrene feedstock contains recycled polystyrene. In some embodiments, the styrenic polymers contain olefins. In some embodiments, the latex and solution with UV-active monomers are used in ink formulations. In some embodiments, latex and solution UV-active monomers can replace styrenated acrylics within flexo and/or gravure ink formulations. Other applications of the latex and solution with UV-active monomers can include, but are not limited to, coatings, paints, adhesives. Additional applications of the latex can include but are not limited to immunoassays.

A latex and solution with UV-active monomers created using styrenic polymers created via the depolymerization of a polystyrene feedstock. In some embodiments the polystyrene feedstock contains recycled polystyrene. In some embodiments, the styrenic polymers contain olefins. In some embodiments, the latex and solution with UV-active monomers are used in ink formulations. In some embodiments, latex and solution UV-active monomers can replace styrenated acrylics within flexo and/or gravure ink formulations. Other applications of the latex and solution with UV-active monomers can include, but are not limited to, coatings, paints, adhesives. Additional applications of the latex can include but are not limited to immunoassays.